
Prat Lab
@PratLab
Followers
282
Following
84
Media
2
Statuses
45
Prat Lab @CRCHUM. Unraveling the migration mechanisms of immune cells across the brain barriers in multiple sclerosis 🔬🧠Tweets by lab members.
Joined August 2021
RT @ChumNeuro: A la retraite du département de Neurosciences @chumontreal @CRCHUM @ChuSteJustine @UMontreal, de riches échanges se font ent….
0
3
0
RT @AkassoglouLab: Comprehensive and insightful review by @PratLab discussing the role of genes & environment on BBB disruption in MS and….
0
10
0
RT @TheLancetNeuro: In our January 2024 issue: the blood–brain barrier in multiple sclerosis, reviewed by Bettina Zierfuss and colleagues f….
0
8
0
RT @endMS: Please share! The 2024-2025 #endMS_SPRINT and 2024 #endMS_SummerSchool competitions are NOW OPEN! Inviting graduate students, po….
0
11
0
RT @Irem_Akbulak_: Excited to be part of @MSCanOfficial #EndMS 2023 in Toronto! I’m grateful for the chance to engage with the MS research….
0
3
0
RT @ScienceTM: In this week’s #neuroimmunology special issue, Thai and @PratLab explore advances in immune cell carriers that ferry therape….
0
22
0
Check out our recent Viewpoint 👇.
Our Viewpoint in the latest special issue of @ScienceTM highlights how immune cell properties can be harnessed to enable targeted drug delivery to brain regions previously inaccessible to free drugs. Read more here: @PratLab.
0
0
1
RT @ghasemloulab: Hoping to spread the word: We've started a study to see how circadian rhythms might affect those living with MS in Canada….
0
21
0
RT @KarineThai_: Very thrilled to have had the opportunity to present my PhD work in the @PratLab about the use of single-cell immune profi….
0
2
0
RT @hwiendl: Leucocyte trafficking inhibition to modulate neuroinflammation: is MCAM a next generation target (and more clever than Nataliz….
pubmed.ncbi.nlm.nih.gov
This scientific commentary refers to ‘MCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytes’ by Charabati et al. (https://doi.org/10.1093/ …
0
2
0
Interested in exciting research on the BBB and MS? 🧠The Prat lab is recruiting talented and motivated graduate students and post-docs! DM us to know more about available positions and send applications to a.prat@umontreal.ca. Please share!.
0
25
30
RT @StephanieZandee: If you’re interested in machine learning, come see my poster p290 ‘Machine Learning Identifies a Combination of Immuno….
0
1
0
RT @AP_Fournier: Which endothelial cell types are most responsive to neuroinflammation?.Read our new article to find out and feel free to p….
neurology.org
Background and ObjectivesMultiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease characterized by infiltration of immune cells in multifocal areas of the CNS. The specific...
0
13
0
Read more about our latest story published in Brain about the role of MCAM+ brain endothelial cells in the recruitment of pathogenic T cells in multiple sclerosis!.
Read about the latest @PratLab research in Brain 🔥🧫🥼🧬🔬we have investigated the role of MCAM on the BBB in multiple sclerosis 👇 #MultipleSclerosis #BBB #endMS @MSSocietyCanada.
0
1
11
Check out our recent study led by @AP_Fournier: CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis
0
2
9
The Prat lab is recruiting graduate students! Please share and send your application to a.prat@umontreal.ca if interested. More info about the research here: @CRCHUM @UMontreal.
neurosciences.umontreal.ca
Dr Prat a obtenu son baccalauréat (B. Sc.) en biochimie à l’Université de Montréal en 1990 et un MD-MSc en 1995. Il a complété sa résidence en neurologie à l’Université […]
0
16
19
RT @BiekeBroux: Our latest paper is out! The first "official" research paper of my beautiful CBN team @uhasselt, with @PhDory as first auth….
0
3
0
RT @RajivWJain: Check out the most recent publication from the Yong lab led by our talented Jeff Dong on how age impacts microglia's capaci….
0
21
0
Huge congratulations to our PhD student @KarineThai_ for the best presentation award in the ADENUM last event! 🥳🤩 we're so proud of you!.
0
1
5